The Composition And Value Of A Portfolio Analysis
![GettyImages-1199010148-cost-analysis-financial-reporting-finance-graph GettyImages-1199010148-cost-analysis-financial-reporting-finance-graph](https://vertassets.blob.core.windows.net/image/002be99b/002be99b-79fa-470e-b8cf-7909351d201f/375_250-gettyimages_1199010148_cost_analysis_financial_reporting_finance_graph.jpg)
One of Premier Consulting’s differentiating offerings is the portfolio analysis, a high-level, integrated evaluation of the scientific, medical, regulatory, and commercial viability of each product within a sponsor’s portfolio. Informed by today’s competitive drug development landscape, as well as by the sponsor’s strategic goals and capabilities, a portfolio analysis involves assessing product concept and differentiation, strategic planning, factoring in unmet patient needs, and estimating timelines and expenses. Gaining a thorough understanding of these factors can significantly impact development strategy and increase the likelihood of marketplace success.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.